 | • レポートコード：MRC2302E0068 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、230ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社では、2021年に244.4億ドルであった世界の移植市場規模が、2022年に264.5億ドルに達し、2027年には年平均成長率8.42%で397.2億ドルまで成長すると予測しています。当調査レポートでは、移植の世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、製品別（免疫抑制剤、組織製品）、用途別（臓器移植、組織移植）、エンドユーザー別（病院、移植センター）、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）の情報が含まれています。なお、当市場の主要企業には、21st Century Medicine、AbbVie Inc.、Acelity L.P. Inc、Arthrex, Inc.、Australian Red Cross Lifeblood、BioLIfe Solutions、CryoLife, Inc、Dr. Franz Kohler Chemie GmbH、Exactech Inc.、LifeCell Corporation、Medtronic PLC、Mid-America Transplant Services、NHS Blood and Transplant、Novartis International AG、Pfizer Inc.、Preservation Solutions, Incなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の移植市場規模：製品別 - 免疫抑制剤の市場規模 - 組織製品の市場規模 ・世界の移植市場規模：用途別 - 臓器移植の市場規模 - 組織移植の市場規模 ・世界の移植市場規模：エンドユーザー別 - 病院における市場規模 - 移植センターにおける市場規模 ・世界の移植市場規模：地域別 - 南北アメリカの移植市場規模 アメリカの移植市場規模 カナダの移植市場規模 ブラジルの移植市場規模 … - アジア太平洋の移植市場規模 日本の移植市場規模 中国の移植市場規模 インドの移植市場規模 韓国の移植市場規模 台湾の移植市場規模 … - ヨーロッパ/中東/アフリカの移植市場規模 イギリスの移植市場規模 ドイツの移植市場規模 フランスの移植市場規模 ロシアの移植市場規模 … - その他地域の移植市場規模 ・競争状況 ・企業情報 |
The Global Transplantation Market size was estimated at USD 24.44 billion in 2021 and expected to reach USD 26.45 billion in 2022, and is projected to grow at a CAGR 8.42% to reach USD 39.72 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Transplantation to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Immunosuppressive Drugs and Tissue Products.
Based on Application, the market was studied across Organ Transplantation and Tissue Transplantation.
Based on End Use, the market was studied across Hospitals and Transplant Centers.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Transplantation market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Transplantation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Transplantation Market, including 21st Century Medicine, AbbVie Inc., Acelity L.P. Inc, Arthrex, Inc., Australian Red Cross Lifeblood, BioLIfe Solutions, CryoLife, Inc, Dr. Franz Kohler Chemie GmbH, Exactech Inc., LifeCell Corporation, Medtronic PLC, Mid-America Transplant Services, NHS Blood and Transplant, Novartis International AG, Pfizer Inc., Preservation Solutions, Inc, Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceutical Industries Ltd, TransMedics, Inc., Transonic, Veloxis Pharmaceuticals A/S, and Zimmer Biomet.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Transplantation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Transplantation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Transplantation Market?
4. What is the competitive strategic window for opportunities in the Global Transplantation Market?
5. What are the technology trends and regulatory frameworks in the Global Transplantation Market?
6. What is the market share of the leading vendors in the Global Transplantation Market?
7. What modes and strategic moves are considered suitable for entering the Global Transplantation Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic diseases
5.1.1.2. Growing awareness about organ donation and registration
5.1.1.3. Rising development of tissue banks
5.1.2. Restraints
5.1.2.1. Shortage of orgain for treatment of organ failure
5.1.3. Opportunities
5.1.3.1. Rising technological advancement in transplant surgeries
5.1.3.2. Growing active initiatives by government and non-government organizations
5.1.4. Challenges
5.1.4.1. Growing ethical and cultural issues associated with transplantations
5.2. Cumulative Impact of COVID-19
6. Transplantation Market, by Product
6.1. Introduction
6.2. Immunosuppressive Drugs
6.3. Tissue Products
7. Transplantation Market, by Application
7.1. Introduction
7.2. Organ Transplantation
7.3. Tissue Transplantation
8. Transplantation Market, by End Use
8.1. Introduction
8.2. Hospitals
8.3. Transplant Centers
9. Americas Transplantation Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Transplantation Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Transplantation Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 21st Century Medicine
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. AbbVie Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Acelity L.P. Inc
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Arthrex, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Australian Red Cross Lifeblood
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. BioLIfe Solutions
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CryoLife, Inc
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Dr. Franz Kohler Chemie GmbH
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Exactech Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. LifeCell Corporation
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Medtronic PLC
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Mid-America Transplant Services
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. NHS Blood and Transplant
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Novartis International AG
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Pfizer Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Preservation Solutions, Inc
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Sanofi S.A.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Stryker Corporation
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Terumo Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Teva Pharmaceutical Industries Ltd
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. TransMedics, Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Transonic
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Veloxis Pharmaceuticals A/S
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Zimmer Biomet
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing